App is temporarily unavailable
Description
“每日医线”是国际系列医学媒体（国际循环、国际糖尿病、国际肝病、国际眼科时讯、肿瘤瞭望）联合推出的一款医学类工具软件，涵盖心血管、内分泌、肝病、眼科、肿瘤等不同临床专科的新闻热点、会议资讯、指南共识、文献速递、病理报告、会议直播、公开课等丰富多彩的内容。“每日医线”致力于搭建临床交流互动的专属社区，让医生足不出户、随时随地均可观看国内外的最新医学资讯，并成为临床工作中的好助手。
Screenshots
每日医线 FAQ
-
Is 每日医线 free?
Yes, 每日医线 is completely free and it doesn't have any in-app purchases or subscriptions.
-
Is 每日医线 legit?
Not enough reviews to make a reliable assessment. The app needs more user feedback.
Thanks for the vote -
How much does 每日医线 cost?
每日医线 is free.
-
What is 每日医线 revenue?
To get estimated revenue of 每日医线 app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.
User Rating
App is not rated in Denmark yet.
Ratings History
每日医线 Reviews
每日医线 Competitors
| Name | Downloads (30d) | Monthly Revenue | Reviews | Ratings | Recent release | |
|---|---|---|---|---|---|---|
CSCO
|
Unlock
|
Unlock
|
0
|
|
1 year ago | |
良医汇-肿瘤医生
|
Unlock
|
Unlock
|
0
|
|
2 weeks ago | |
海心医生
|
Unlock
|
Unlock
|
0
|
|
1 year ago | |
乐问医学
乐问医学-做大数据+AI与生命科学的链接者
|
Unlock
|
Unlock
|
0
|
|
1 month ago | |
DrKing
|
Unlock
|
Unlock
|
0
|
|
3 years ago | |
肝胆相照专家版
|
Unlock
|
Unlock
|
0
|
|
2 months ago | |
罕见病新进展
|
Unlock
|
Unlock
|
0
|
|
6 months ago | |
QICC2024
|
Unlock
|
Unlock
|
0
|
|
1 month ago | |
医知源-医生的最佳诊疗决策辅助工具
循证、全面、及时、互助的疾病知识库
|
Unlock
|
Unlock
|
0
|
|
6 months ago | |
HCV DDI
|
Unlock
|
Unlock
|
0
|
|
2 years ago |
每日医线 Installs
Last 30 days
每日医线 Revenue
Last 30 days每日医线 Revenue and Downloads
Gain valuable insights into 每日医线 performance with our analytics.
Sign up now to access downloads, revenue, and more.
Sign up now to access downloads, revenue, and more.
App Info
- Category
- Medical
- Publisher
- Tian Shuo
- Languages
- English
- Recent release
- 1.7.9 (1 year ago )
- Released on
- Jan 4, 2021 (3 years ago )
- Also available in
- China , Poland , Italy , Japan , South Korea , Kuwait , Kazakhstan , Lebanon , Mexico , Malaysia , Nigeria , Netherlands , Norway , New Zealand , Peru , Philippines , Pakistan , India , Portugal , Romania , Russia , Saudi Arabia , Sweden , Singapore , Thailand , Türkiye , Taiwan , Ukraine , United States , Vietnam , South Africa , Dominican Republic , Argentina , Austria , Australia , Azerbaijan , Belgium , Brazil , Belarus , Canada , Switzerland , Chile , Colombia , Czechia , Germany , Denmark , United Arab Emirates , Algeria , Ecuador , Egypt , Spain , Finland , France , United Kingdom , Greece , Hong Kong SAR China , Hungary , Indonesia , Ireland , Israel
- Last Updated
- 3 months ago
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.